Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1

Interventions

venetoclax 12Cytarabine 12Azacitidine 10Decitabine 8Daunorubicin 7Cyclophosphamide 7Busulfan 6fludarabine phosphate 5Idarubicin 5Gemtuzumab 5Thiotepa 3Stem Cell Transplantation 3Filgrastim 3Cyclosporine 3vosaroxin 2fludarabine 2Whole-Body Irradiation 2Tretinoin 2Sorafenib 2Radiotherapy 2Methylprednisolone 2Methotrexate 2Melphalan 2Injections 2Etoposide 2Cladribine 2CPX-351 2Antilymphocyte Serum 2Abatacept 2vedolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Leukemia, Myeloid, Acute × Transplantation, Homologous × Clear all
NCT01588951 2018-08-14

Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2/3 Terminated
10 enrolled 8 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡